Volume | 353,700 |
|
|||||
News | - | ||||||
Day High | 10.20 | Low High |
|||||
Day Low | 9.54 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Inovio Pharmaceuticals Inc New | INO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
10.20 | 9.54 | 10.20 | 9.68 | 10.20 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
6,105 | 353,700 | $ 9.80 | $ 3,465,649 | - | 3.888 - 14.748 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:50:06 | formt | 200 | $ 9.58 | USD |
Inovio Pharmaceuticals Inc New Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
226.23M | 23.37M | - | 832k | -135.12M | -5.78 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Inovio Pharmaceuticals News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 11.67 | 11.8999 | 8.96 | 10.51 | 448,447 | -2.09 | -17.91% |
1 Month | 10.81 | 14.748 | 8.96 | 11.97 | 451,283 | -1.23 | -11.38% |
3 Months | 6.80 | 14.748 | 4.73 | 9.66 | 492,047 | 2.78 | 40.88% |
6 Months | 5.76 | 14.748 | 3.888 | 7.11 | 2,124,113 | 3.82 | 66.32% |
1 Year | 10.416 | 14.748 | 3.888 | 6.65 | 4,238,840 | -0.836 | -8.03% |
3 Years | 104.2524 | 123.96 | 3.888 | 36.76 | 5,020,196 | -94.67 | -90.81% |
5 Years | 45.60 | 426.00 | 3.888 | 122.40 | 9,094,314 | -36.02 | -78.99% |
Inovio Pharmaceuticals Description
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. |